Jaguar Health (JAGX) Total Liabilities (2014 - 2026)
Jaguar Health (JAGX) posted quarterly Total Liabilities of $53.2 million for Q1 2026, up 10.47% year-over-year from $48.1 million in Q1 2025, and down 6.71% quarter-over-quarter from $57.0 million in Q4 2025.
Jaguar Health (JAGX) Total Liabilities (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has reported Total Liabilities for 13 consecutive years, with $53.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Liabilities rose 10.47% year-over-year to $53.2 million; the TTM figure through Mar 2026 stood at $53.2 million (up 10.47% YoY), while the FY2025 annual figure was $57.0 million, up 28.27% from the prior year.
- Total Liabilities retreated to $53.2 million in Q1 2026 per JAGX's latest filing, from $57.0 million in the prior quarter.
- Across five years, Total Liabilities topped out at $57.0 million in Q4 2025 and bottomed at $41.1 million in Q1 2024.
- Historically, Total Liabilities has averaged $46.4 million across 5 years, with a median of $45.9 million in 2023.
- Annual changes were most pronounced in 2024 — Total Liabilities decreased 16.61% — and 2025, when it increased 28.27%.
- Jaguar Health's Total Liabilities stood at $48.8 million in 2022, then declined by 6.03% to $45.9 million in 2023, then slipped by 3.1% to $44.4 million in 2024, then advanced by 28.27% to $57.0 million in 2025, then slipped by 6.71% to $53.2 million in 2026.
- Business Quant data shows JAGX's Total Liabilities at $53.2 million in Q1 2026, $57.0 million in Q4 2025, and $45.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 4.20 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 4.00 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 4.20 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 3.22 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.35 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 10.03 Bn |
| 10 | Jaguar Health | 447,549.24 | -9.62 Mn | 19.11 Mn | 53.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 53.19 Mn |
| Dec 31, 2025 | 57.01 Mn |
| Sep 30, 2025 | 45.11 Mn |
| Jun 30, 2025 | 41.39 Mn |
| Mar 31, 2025 | 48.15 Mn |
| Dec 31, 2024 | 44.45 Mn |
| Sep 30, 2024 | 42.88 Mn |
| Jun 30, 2024 | 42.40 Mn |
| Mar 31, 2024 | 41.09 Mn |
| Dec 31, 2023 | 45.87 Mn |
| Sep 30, 2023 | 43.96 Mn |
| Jun 30, 2023 | 46.34 Mn |
| Mar 31, 2023 | 49.27 Mn |
| Dec 31, 2022 | 48.81 Mn |
| Sep 30, 2022 | 47.69 Mn |
| Jun 30, 2022 | 47.13 Mn |
| Mar 31, 2022 | 44.80 Mn |
| Dec 31, 2021 | 41.41 Mn |
| Sep 30, 2021 | 37.70 Mn |
| Jun 30, 2021 | 37.75 Mn |